IGC Pharma Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 2005
Revenue	0.91	0.4	0.9	4.07	5.12	2.19	0.58	6.37	7.68	2.27	Upgrade
Revenue Growth (YoY)	129.47%	-55.79%	-77.95%	-20.41%	133.29%	277.86%	-90.88%	-17.10%	237.87%	-71.69%	Upgrade
Cost of Revenue	0.47	0.2	0.79	3.96	4.98	2.11	0.36	5.52	7.1	1.89	Upgrade
Gross Profit	0.44	0.19	0.11	0.12	0.13	0.08	0.22	0.84	0.58	0.38	Upgrade
Selling, General & Admin	8.55	13.29	7.91	5.97	3.52	1.73	2.27	2.7	4.14	2.18	Upgrade
Research & Development	3.46	2.33	0.93	1.01	1.26	0.14	0	0	0	0	Upgrade
Other Operating Expenses	0	0	0	0	0	0	0	0.73	0.78	0.71	Upgrade
Operating Expenses	12.01	15.62	8.84	6.98	4.78	1.87	2.27	3.43	4.92	2.89	Upgrade
Operating Income	-11.57	-15.43	-8.72	-6.86	-4.64	-1.79	-2.05	-2.59	-4.34	-2.51	Upgrade
Interest Expense / Income	0	0	0	0	0	0	0	0.21	0.29	0.29	Upgrade
Other Expense / Income	-0.07	-0.41	0.09	0.45	-0.55	-0	-0.2	0.01	-0.02	0.22	Upgrade
Pretax Income	-11.51	-15.02	-8.81	-7.32	-4.1	-1.79	-1.85	-2.81	-4.61	-3.02	Upgrade
Income Tax	0	0	0	0	0	0	0.01	0	0.01	0	Upgrade
Net Income	-11.51	-15.02	-8.81	-7.32	-4.1	-1.79	-1.87	-2.81	-4.61	-3.02	Upgrade
Shares Outstanding (Basic)	53	50	42	39	35	28	26	16	15	8	Upgrade
Shares Outstanding (Diluted)	53	50	42	39	35	28	26	16	15	8	Upgrade
Shares Change	5.17%	19.13%	6.26%	11.58%	26.69%	8.88%	56.58%	11.06%	79.83%	17.78%	Upgrade
EPS (Basic)	-0.22	-0.30	-0.21	-0.19	-0.13	-0.06	-0.07	-0.17	-0.31	-0.37	Upgrade
EPS (Diluted)	-0.22	-0.30	-0.21	-0.19	-0.13	-0.06	-0.07	-0.17	-0.31	-0.37	Upgrade
Free Cash Flow	-6.82	-7.67	-12.27	-13.07	-3.35	-2.07	-1.54	-0.28	-2.66	-1.74	Upgrade
Free Cash Flow Per Share	-0.13	-0.15	-0.29	-0.33	-0.10	-0.07	-0.06	-0.02	-0.18	-0.21	Upgrade
Gross Margin	48.52%	48.87%	12.58%	2.82%	2.58%	3.74%	37.60%	13.25%	7.55%	16.79%	Upgrade
Operating Margin	-1270.14%	-3886.15%	-971.49%	-168.57%	-90.75%	-81.58%	-353.82%	-40.65%	-56.54%	-110.40%	Upgrade
Profit Margin	-1263.01%	-3782.37%	-981.18%	-179.64%	-80.08%	-81.44%	-321.74%	-44.11%	-60.08%	-132.97%	Upgrade
Free Cash Flow Margin	-748.52%	-1931.74%	-1366.37%	-320.87%	-65.38%	-94.25%	-264.79%	-4.40%	-34.64%	-76.50%	Upgrade
EBITDA	-10.85	-14.37	-8.33	-7.17	-4.04	-1.77	-1.46	-1.86	-3.54	-2.02	Upgrade
EBITDA Margin	-1190.89%	-3618.39%	-927.95%	-176.11%	-78.89%	-80.57%	-250.96%	-29.29%	-46.11%	-88.81%	Upgrade
Depreciation & Amortization	0.66	0.65	0.48	0.14	0.06	0.02	0.4	0.73	0.78	0.71	Upgrade
EBIT	-11.51	-15.02	-8.81	-7.32	-4.1	-1.79	-1.85	-2.59	-4.32	-2.73	Upgrade
EBIT Margin	-1263.01%	-3782.37%	-981.18%	-179.64%	-80.04%	-81.44%	-319.25%	-40.74%	-56.28%	-120.14%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).